Overweight and Obesity Clinical Trial
Official title:
A Randomized Controlled Trial Comparing Weight Loss Effects Between the Keyto Virtual "Ketogenic Diet" Program Compared to a Standard-care Weight Loss App
Verified date | August 2021 |
Source | University of British Columbia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Very low-carbohydrate ketogenic diet may have beneficial metabolic and weight loss effects, however, adhering to this diet may be challenging. Keyto is a self-monitoring and app-enhanced intervention to help individuals learn about and monitor their breath acetone (a measure of ketosis) levels to promote dietary change and weight loss. The purpose of this research is to test the Keyto self-monitoring + app intervention against a "standard of care" weight loss dietary app (Weight Watchers). 144 participants will be recruited through Facebook ads, provide online consent, and will be randomized to one of the two conditions. Weight loss after 12 weeks will be assessed as the primary outcome, with weight loss at 24 and 48 weeks being secondary outcomes. Blood samples will be collected at baseline and 12 weeks with optional blood samples at 48 weeks follow up.
Status | Completed |
Enrollment | 155 |
Est. completion date | August 11, 2021 |
Est. primary completion date | January 2, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 64 Years |
Eligibility | Inclusion Criteria: - Age 18-64 - Living in the State of California - Body mass index (BMI) 27-43 - Must speak, read, and comprehend English - Access to reliable internet and wi-fi - Must have a valid email address and phone number - Must have an Apple iPhone (iPhone 7 or later, iOS 11 or later) with cellular data plan - Must have a kitchen and be willing to cook - Willingness to reduce carbohydrate intake to less than 30g/day - Willingness to restrict intake of added sugar, bread, grain, rice, pasta, sweets, most fruits, pastries, and other carbohydrates - Willingness to comply with a strict diet for 12 months - Willingness to eat a diet that is primarily plant and fish-based - Interest in losing weight Exclusion Criteria: - HIV or immunocompromised - Current or past cancer diagnosis - Pregnant, breastfeeding, or planned pregnancy in next 12 months - Beginning or ending hormonal contraception in next 12 months - Current diagnosis of diabetes - History of heart attack or stent - Currently taking glucose-lowering drugs, statins, or oral steroids - History of gastric bypass surgery or any other weight-loss surgery - History of anorexia or bulimia - History of mental illness - Current smoker or smoked cigarettes within past 12 months - Currently eating fewer than 50 g carbohydrates per day - Have tried a low-carb, high fat (ketogenic diet) within the past 3 months - Recent weight loss or gain of more than 5% body weight in past 6 months - Previous experience with the Weight Watchers diet app - Experience with a low-carbohydrate of ketogenic diet within past 6 months |
Country | Name | City | State |
---|---|---|---|
Canada | University of British Columbia | Kelowna | British Columbia |
Lead Sponsor | Collaborator |
---|---|
University of British Columbia |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Fasting albumin | Blood test will determine changes in serum albumin | 12 and 48 weeks from baseline | |
Other | Fasting globulin | Blood test will determine changes in serum globulin | 12 and 48 weeks from baseline | |
Other | Fasting total bilirubin | Blood test will determine changes in serum bilirubin | 12 and 48 weeks from baseline | |
Other | Fasting alkaline phosphatase | Blood test will determine changes in serum alkaline phosphatase | 12 and 48 weeks from baseline | |
Other | Fasting aspartate aminotransferase | Blood test will determine changes in serum aspartate aminotransferase | 12 and 48 weeks from baseline | |
Other | Fasting alanine aminotransferase | Blood test will determine changes in serum alanine aminotransferase | 12 and 48 weeks from baseline | |
Primary | Change in body mass at 12 weeks | Change in body mass (in kilograms) | 12 weeks from baseline | |
Secondary | Change in body mass at 24 and 48 weeks | Change in body mass (in kilograms) | 24 and 48 weeks from baseline | |
Secondary | Carbohydrate intake | Total consumption of carbohydrates in 24 hour period (in grams) | 12, 24, and 48 weeks from baseline | |
Secondary | Total fat intake | Total consumption of fat in 24 hour period (in grams) | 12, 24, and 48 weeks from baseline | |
Secondary | Saturated fat intake | Total consumption of saturated fat in 24 hour period (in grams) | 12, 24, and 48 weeks from baseline | |
Secondary | Polyunsaturated fat intake | Total consumption of polyunsaturated fat in 24 hour period (in grams) | 12, 24, and 48 weeks from baseline | |
Secondary | Monounsaturated fat intake | Total consumption of monounsaturated fat in 24 hour period (in grams) | 12, 24, and 48 weeks from baseline | |
Secondary | Total energy intake | Total energy intake in 24 hour period (in kilocalories) | 12, 24, and 48 weeks from baseline | |
Secondary | HbA1C | Blood test will be used to determine changes in HbA1C | 12 and 48 weeks from baseline | |
Secondary | Fasting glucose | Blood test will be used to determine changes in fasting serum glucose | 12 and 48 weeks from baseline | |
Secondary | Fasting insulin | Blood test will be used to determine changes in fasting serum insulin | 12 and 48 weeks from baseline | |
Secondary | Fasting high-sensitivity C-reactive protein | Blood test will be used to determine changes in fasting serum high-sensitivity C-reactive protein | 12 and 48 weeks from baseline | |
Secondary | Fasting homeostasis model assessment of insulin resistance (HOMA-IR) | Blood test will be used to determine changes in HOMA-IR | 12 and 48 weeks from baseline | |
Secondary | Fasting total cholesterol | Blood test will be used to determine changes in serum total cholesterol | 12 and 48 weeks from baseline | |
Secondary | Fasting high-density lipoprotein (HDL) cholesterol | Blood test will be used to determine changes in serum HDL cholesterol | 12 and 48 weeks from baseline | |
Secondary | Fasting lipoprotein fractions | Blood test will determine changes in serum lipoprotein fractions measured by ion mobility | 12 and 48 weeks from baseline | |
Secondary | Fasting lipoprotein (a) | Blood test will determine changes in serum lipoprotein (a) | 12 and 48 weeks from baseline | |
Secondary | Fasting triglycerides | Blood test will determine changes in serum trigylcerides | 12 and 48 weeks from baseline | |
Secondary | Fasting non-HDL cholesterol | Blood test will determine changes in serum non-HDL cholesterol | 12 and 48 weeks from baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03994419 -
PErioperAtive CHildhood ObesitY
|
||
Recruiting |
NCT05354245 -
Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)
|
N/A | |
Completed |
NCT03602001 -
Attentive Eating for Weight Loss
|
N/A | |
Recruiting |
NCT06269159 -
The Power of 24-hour: Co-designing Intervention Components
|
||
Completed |
NCT03377244 -
Healthy Body Healthy Souls in the Marshallese Population
|
N/A | |
Completed |
NCT02996864 -
Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II
|
N/A | |
Completed |
NCT04647149 -
Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity
|
N/A | |
Terminated |
NCT03914066 -
A Group-based Treatment of Overweight and Obesity in Primary Care
|
N/A | |
Completed |
NCT03685656 -
Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers
|
N/A | |
Completed |
NCT05051579 -
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
|
Phase 2 | |
Completed |
NCT04611477 -
Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals
|
N/A | |
Active, not recruiting |
NCT05330247 -
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study
|
N/A | |
Completed |
NCT03599115 -
Effects of Inhibitory Control Training in Eating Behaviors
|
N/A | |
Recruiting |
NCT06094231 -
Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study
|
N/A | |
Recruiting |
NCT05938894 -
Train Your Brain - Executive Function
|
N/A | |
Recruiting |
NCT05987306 -
A Self-compassion Focused Intervention for Internalized Weight Bias and Weight Loss
|
N/A | |
Completed |
NCT03792685 -
Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention
|
N/A | |
Completed |
NCT05055362 -
Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study
|
N/A | |
Completed |
NCT04520256 -
Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy
|
Phase 2/Phase 3 | |
Completed |
NCT04979234 -
A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome
|
N/A |